Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental mouse model of sepsis

J Wang, Y Wang, J Xie, Z Zhao, S Gupta… - Blood, The Journal …, 2021 - ashpublications.org
… survival by activating PI3K/AKT signaling. … maintains the stemness of cancer stem cells through
AKT signaling. We therefore sought to … apoptosis by maintaining AKT phosphorylation. (A) …

Cancer stem cells and epithelial–mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches

D Fang, H Kitamura - International Journal of Urology, 2018 - Wiley Online Library
… , where it is thought to function in maintaining stem cell … in the expression of proteins involved
in the PI3K/AKT pathway; … evidence of the participation of PD-L1 in the activity of CSCs. It is …

MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation

N Dastmalchi, R Safaralizadeh… - Molecular Biology …, 2021 - Springer
… the PD-L1 expression and controlling PTEN/PI3K/AKT/mTOR. … we evaluated PD-L1 transcript
and protein expression levels … of c-Myc in sustaining the proliferation and chemoresistant …

[HTML][HTML] Targeting PD-1/PD-L1 in cancer immunotherapy: an effective strategy for treatment of triple-negative breast cancer (TNBC) patients

S Kumar, M Chatterjee, P Ghosh, KK Ganguly, M Basu… - Genes & …, 2023 - Elsevier
Maintaining the balance between eliciting immune responses … PTEN which terminates the
PI3K-AKT-PKCθ pathway and … by inducing expression of HLA-G, PD-L1 as well as promoting

[HTML][HTML] Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance

MR Makena, A Ranjan, V Thirumala… - Biochimica et Biophysica …, 2020 - Elsevier
… Additionally, PD-L1 was shown to promote stemness in breast cancer by increasing the
expression of stemness factors OCT4 and Nanog by sustained PI3K/Akt pathway activation [60]. …

[HTML][HTML] Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity

R Zhang, J Tu, S Liu - Seminars in cancer biology, 2022 - Elsevier
… -150 and promoted the expression of these genes to sustained … via EP4/PI3K/AKT/NOTCH/WNT
pathway. In addition, Aberrantly … Studies showed that PD-L1 expression was positively …

Cancer stem cell-targeted therapeutic approaches for overcoming trastuzumab resistance in HER2-positive breast cancer

Y Qiu, L Yang, H Liu, X Luo - Stem Cells, 2021 - academic.oup.com
PD-L1 was revealed to play an important role in sustaining the stemness of breast cancer
cells by activating the PI3K/AKT … - 96 CAFs also promote EMT transformation by activating TGF-…

[HTML][HTML] Complete response of chemo-refractory metastatic metaplastic breast cancer to paclitaxel-immunotherapy combination

AD Al Sayed, MA Elshenawy, A Tulbah… - The American Journal …, 2019 - ncbi.nlm.nih.gov
PD-L1 promotes cancer stem-like cells by maintaining the PI3K/AKT pathway and their
downstream stem-related embryonic antigens OCT4 and Nanog [20]. Indeed, MPBCs were found …

PD‐1/PDL1 immune checkpoint: potential target for cancer therapy

FK Dermani, P Samadi, G Rahmani… - Journal of cellular …, 2019 - Wiley Online Library
… PD-1 and PD-L1 enhances the T-cell response and mediates … has been shown crucial to
maintaining homeostasis of the … the PI3K/Akt pathway regulates PD-L1 expression by either …

[HTML][HTML] Research progress on the intrinsic non‑immune function of PDL1 in tumors

J Deng, W Jiang, L Liu, W Zhan, Y Wu… - Oncology …, 2023 - spandidos-publications.com
… of PD-L1, which strengthened PD-L1 expression and promotedbreast EMT by activating
PI3K/Akt pathway and that PD-L1PD-L1 is considered essential in maintaining the stemness …